Incident HSV-2 infections are common among HIV-1-discordant couples

Journal of Infectious Diseases

Volumn 208, Issue 7, 2013, Pages 1093-1101

  Muiru, Anthony N ^a   Guthrie, Brandon L ^b,c   Bosire, Rose ^e   Merkel, Michele ^d   Liu, Amy Y ^b   Choi, Robert Y ^d   Lohman Payne, Barbara ^c,d   Gatuguta, Ann ^f   Mackelprang, Romel D ^c   Kiarie, James N ^g,h,i   Farquhar, Carey ^b,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Departments of Biostatistics and Epidemiology   (United States)

^c FHI 360   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^f KENYATTA UNIVERSITY   (Kenya)

^g Department of Obstetrics and Gynecology ^*  (Kenya)

^h UNIVERSITY OF NAIROBI   (Kenya)

ⁱ KENYATTA NATIONAL HOSPITAL   (Kenya)

Author keywords

Africa; antiviral; couples; discordant; ELISA; genital ulcer disease; herpes; HIV; HSV 2; incidence; Kenya; prevalence; prevention; seroconvert; serodiscordant; transmission

Indexed keywords

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAMARITAL SEX; FEMALE; FOLLOW UP; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HERPES SIMPLEX VIRUS 2 INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; KENYA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL TRANSMISSION; UNPROTECTED SEX; VIRUS TRANSMISSION; AFRICA; COUPLES; DISCORDANT; FAMILY SIZE; GENITAL HERPES; GENITAL ULCER DISEASE; HSV-2; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PREVALENCE; PREVENTION; SEROCONVERT; SERODISCORDANT; TRANSMISSION; VIROLOGY;

ANTIVIRUS AGENT;

AFRICA; ANTIVIRAL; COUPLES; DISCORDANT; ELISA; GENITAL ULCER DISEASE; HERPES; HIV; HSV-2; INCIDENCE; KENYA; PREVALENCE; PREVENTION; SEROCONVERT; SERODISCORDANT; TRANSMISSION;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILY CHARACTERISTICS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; KENYA; MALE; PREVALENCE;

EID: 84887304795     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit303     Document Type: Article

References (41)

1. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004; 11(Suppl 1):24-35A
2. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 2008; 86:805-12, A
3. Strick LB, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis 2006; 43:347-56
4. Carney O, Ross E, Bunker C, Ikkos G, Mindel A. A prospective study of the psychological impact on patients with a first episode of genital herpes. Genitourin Med 1994; 70:40-5
5. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-Analysis of longitudinal studies. AIDS 2006; 20:73-83
6. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280:61-6
7. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186:1718-25
8. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: Opportunities for intervention. J Infect Dis 2000; 182:1090-6
9. Baeten JM, McClelland RS, Corey L, et al. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: A randomized clinical trial. J Infect Dis 2004; 189:1466-71
10. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-53
11. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: An evidence-based review. Arch Int Med 2008; 168:1137-44
12. Celum C, Wald A, Lingappa JR, et al. Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-39
13. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20
14. Chemaitelly H, Shelton JD, Hallett TB, Abu-Raddad LJ. Only a fraction of new HIV infections occur within identifiable stable discordant couples in Sub-Saharan Africa. AIDS 2013; 27:251-60
15. Dunkle KL, Stephenson R, Karita E, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: An analysis of survey and clinical data. Lancet 2008; 371:2183-91
16. Carpenter LM, Kamali A, Ruberantwari A, Malamba SS, Whitworth JA. Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners. AIDS 1999; 13:1083-9
17. Robinson NJ, Mulder D, Auvert B, Whitworth J, Hayes R. Type of partnership and heterosexual spread of HIV infection in rural Uganda: Results from simulation modeling. Int J STD AIDS 1999; 10:718-25
18. Mugo N, Dadabhai SS, Bunnell R, et al. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya. Sex Transm Dis 2011; 38:1059-66
19. Guthrie BL, Choi RY, Bosire R, et al. Predicting pregnancy in HIV-1-discordant couples. AIDS Behav 2010; 14:1066-71
20. Guthrie BL, Lohman-Payne B, Liu AY, et al. HIV-1-specific enzymelinked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls. Clin Vaccine Immunol 2012; 19:1798-805
21. Golden MR, Ashley-Morrow R, Swenson P, Hogrefe WR, Handsfield HHWald A. Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex Trans Dis 2005; 32:771-7
22. Laeyendecker O, Henson C, Gray RH, et al. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans. J Clin Microbiol 2004; 42:1794-6
23. Smith JS, Bailey RC, Westreich DJ, et al. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing. Sex Transm Infect 2009; 85:92-6
24. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-19
25. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399-410
26. Mujugira A, Morrow RA, Celum C, et al. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries. Sex Transm Infect 2011; 87:238-41
27. Lingappa J, Nakku-Joloba E, Magaret A, et al. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans. Int J STD AIDS 2010; 21:611-6
28. Sobngwi-Tambekou J, Taljaard D, Lissouba P, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: Results of a longitudinal study in Orange Farm, South Africa. J Infect Dis 2009; 199: 958-64
29. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298-309
30. Mehta SD, Moses S, Parker CB, Agot K, Maclean I, Bailey RC. Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS 2012; 26:1141-9
31. Tobian AA, Kigozi G, Redd AD, et al. Male circumcision and herpes simplex virus type 2 infection in female partners: A randomized trial in Rakai, Uganda. J Infect Dis 2012; 205:486-90
32. Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004; 10:530-6
33. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Int Med 1992; 116:197-202
34. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100-6
35. Wald A, Krantz E, Selke S, Lairson E, Morrow RA, Zeh J. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 2006; 194:42-52
36. Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513-21
37. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770-5
38. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Int Med 1994; 121:847-54
39. Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Int Med 1992; 116:433-7
40. Cates W, Jr. After CAPRISA 004: Time to re-evaluate the HIV lexicon. Lancet 2010; 376:495-6
41. Andrei G, Lisco A, Vanpouille C, et al. Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. Cell Host Microbe 2011; 10:379-89